dinitrochlorobenzene
Small moleculeexperimental
2,4-Dinitrochlorobenzene (DNCB) is an organic compound with the chemical formula (O2N)2C6H3Cl. It is a yellow solid that is soluble in organic solvents. It is an intermediate for the industrial production of other compounds. — Wikipedia
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 2, 1999 (NCT00002031)
Timeline
1990s
- Jan 1, 1999
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusINHIBITOR
Human immunodeficiency virus inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
O=[N+]([O-])c1ccc(Cl)c([N+](=O)[O-])c1- Mol. weight
- 202.55 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- Wikipedia2,4-Dinitrochlorobenzene ↗
- ChEMBLCHEMBL292687 ↗
Also known as
- 1-chloro-2,4-dinitrobenzene
- 1-chloro-2,4-dinitrobenzene
- dinitrochlorobenzene
- dinitrochlorobenzene
- dinitrochlorobenzene
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00002031 | N/A | Nov 2, 1999 | University of California, San Francisco |
| NCT00002175 | Phase 1 | Nov 2, 1999 | The Honolulu Medical Group |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| The Honolulu Medical Group | Academic/Hospital | 1 | 1 | 1 | 1999 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | 1999 |
2 organizations
Page 1 / 1